...
首页> 外文期刊>Emerging Infectious Diseases >Clinical Risk Factors for Severe Clostridium difficile–associated Disease
【24h】

Clinical Risk Factors for Severe Clostridium difficile–associated Disease

机译:重度艰难梭菌相关疾病的临床危险因素

获取原文

摘要

Identifying patients who are at high risk for severe Clostridium diffi cile–associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes. Therefore, we compared clinical features asso-ciated with severe versus nonsevere CDAD by retrospec-tively reviewing records of hospitalized patients whose fecal assays were positive for C. diffi cile toxin. Of 336 patients, 12.2% had severe disease and 10.1% died from all causes. Regression modeling showed the following to be signifi cant-ly associated with severe CDAD (p70 years (odds ratio [OR] 3.35), maximum leukocyte count >20,000 cells/mL (OR 2.77), minimum albumin level 2 mg/dL (OR 2.47), small bowel obstruction or ileus (OR 3.06), and computed tomog-raphy scan showing colorectal in. ammation (OR 13.54). These clinical and laboratory markers for severe disease may be useful for identifying patients at risk for serious out-comes or death
机译:在感染过程中尽早发现高危重症艰难梭菌相关疾病(CDAD)的患者可能有助于临床医生改善结局。因此,我们通过回顾性回顾了粪便检测结果为艰难梭菌毒素阳性的住院患者的记录,比较了重度和非重度CDAD的临床特征。在336例患者中,有12.2%患有严重疾病,10.1%死于各种原因。回归模型显示以下与严重CDAD(p70年(比值比[OR] 3.35),白细胞最大数量> 20,000细胞/ mL(OR 2.77),最低白蛋白水平2 mg / dL(OR 2.47)有显着相关性),小肠梗阻或肠梗阻(OR 3.06)以及计算机断层扫描显示结肠直肠炎(OR 13.54),这些用于严重疾病的临床和实验室标志物可能有助于识别有严重结局或死亡

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号